ArticleJournal of gynecologic oncology2026
LKB1 attenuates the transport activity of GLUT1 by regulating the alternative splicing of PKM1/PKM2 in cervical cancer.
Article in Journal of gynecologic oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveLiver kinase B1 (LKB1) is a tumor suppressor that negatively regulates glucose transporter 1 (GLUT1) in Peutz-Jeghers Syndrome, but its mechanism in cervical cancer is unclear.
methodsLKB1 expression was detected in cervical cancer specimens by real-time polymerase chain reaction. The double directional genetic manipulation, Nuclear and Cytoplasmic Protein separation technique and immunofluorescence were performed to detect the regulatory relationships among LKB1, pyruvate kinase isozyme type M2 (PKM2), hypoxia-inducible factor 1α (HIF-1α), and GLUT1 in cervical cancer cells, and Plasma Membrane and Cytoplasmic Protein separation technique and glucose uptake assay were used to verify the transport activity of GLUT1. LKB1-overexpression and -knockdown cervical cancer cell lines were generated in vitro.
resultsLKB1 messenger RNA level was lower in cervical cancer tissues than in matched paracancerous tissues. LKB1 was highly expressed in the cytoplasm of C33A, but was absent in its nucleus. And LKB1 was absent in SiHa. LKB1 regulated the alternative splicing of PKM1/PKM2. LKB1 overexpression significantly downregulated the PKM2pS37 expression in the nucleus and cytoplasm, the HIF-1α expression in the nucleus, and the GLUT1 expression in the plasma membrane. PKM2 knockdown reduced the nuclear accumulation of HIF-1α. Moreover, PKM2/HIF-1α knockdown reduced the glucose uptake of GLUT1. LKB1 negatively regulated the interaction between PKM2 and HIF-1α via AMPK signaling so as to inhibit the malignant phenotype of cervical cancer cells.
conclusionLKB1 attenuates GLUT1 transport activity by inhibiting the PKM2/HIF-1α pathway, supporting the important roles of PKM2 and HIF-1α in the pathogenesis of cervical cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.